Clinical Trials Logo

Clinical Trial Summary

Prospective, single-arm, multi-center registry study A total of 50 subjects with Type B aortic dissection who meet all inclusion and exclusion criteria will be included.

Patients will be treated with TEVAR using conformable TAG endograft (Gore). Patients will be followed clinically for 12 months after the procedure. CT will be performed at 12 months.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02816333
Study type Observational
Source Yonsei University
Contact
Status Withdrawn
Phase
Start date June 2016
Completion date June 2020

See also
  Status Clinical Trial Phase
Recruiting NCT01984905 - Study of Prognostic Factors in Aortic Dissection Type B N/A
Completed NCT00908388 - Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection N/A
Recruiting NCT05479305 - Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies N/A
Completed NCT01407159 - A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting N/A
Not yet recruiting NCT05349071 - PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR) N/A
Not yet recruiting NCT06289777 - Aortic Remodeling After Endovascular Management of Type B Aortic Dissection.
Enrolling by invitation NCT03845829 - LSA Reconstruction With Laser Fenestration During the TEVAR N/A
Active, not recruiting NCT04765605 - Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study) N/A
Recruiting NCT06087029 - IMPRoving Outcomes in Vascular DisEase- Aortic Dissection N/A